Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia.

Bartlett MJ, Flores AJ, Ye T, et al. "Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia." Exp. Neurol.. 2020;333:113413.